Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 53, Issue 10, 2004, Pages 1359-1364

  Takahashi, Naohiko ^a   Anan, Futoshi ^a   Nakagawa, Mikiko ^a   Yufu, Kunio ^a   Ooie, Tatsuhiko ^a   Nawata, Tomoko ^a   Shigematsu, Sakuji ^a   Hara, Masahide ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CONTRAST MEDIUM; IODINE 123; NORADRENALIN;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART FUNCTION TEST; HEART INNERVATION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MICROALBUMINURIA; MORTALITY; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; URINARY EXCRETION;

3-IODOBENZYLGUANIDINE; AGED; AGING; ALBUMINURIA; AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; NOREPINEPHRINE; RADIOPHARMACEUTICALS;

EID: 4544335786     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.03.024     Document Type: Article

References (38)

1. Borch-Johnsen K., Kreiner S. Proteinuria Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J. 294:1987;1651-1654
2. Mogensen C.E. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 254:2003;45-66
3. Savage S., Estacio R.O., Jeffers B., et al. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 19:1996;1243-1248
4. Ewing D.J. Diabetic autonomic neuropathy and the heart. Diabetes Res Clin Pract. 30:(suppl):1996;S31-S36
5. Clarke C.F., Eason M., Reilly A., et al. Autonomic nerve function in adolescents with type 1 diabetes mellitus Relationship to microalbuminuria. Diabet Med. 16:1999;550-554
6. Lafferty A.R., Werther G.A., Clarke C.F. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care. 23:2000;533-538
7. Rutter M.K., McComb J.M., Brady S., et al. Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria. Clin Auton Res. 8:1998;251-257
8. Neil H.A., Thompson A.V., John S., et al. Diabetic autonomic neuropathy the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med. 6:1989;20-24
9. Smulders Y.M., Jager A., Gerritsen J., et al. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes The HOORN Study. Diabetes Care. 23:2000;1369-1374
10. Takahashi N., Nakagawa M., Saikawa T., et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol. 38:2001;232-237
11. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care. 21:1998;2116-2122
12. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy Comparison to necropsy findings. Am J Cardiol. 67:1986;450-458
13. Takahashi N., Nakagawa M., Saikawa T., et al. Noninvasive assessment of the cardiac baroreflex Response to downward tilting and comparison with the phenylephrine method. J Am Coll Cardiol. 34:1999;211-215
14. Sato T., Nishinaga M., Kawamoto A., et al. Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension. 21:1993;866-874
15. Nakagawa M., Iwao T., Ishida S., et al. Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects. Heart. 79:1998;493-496
16. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
17. Goligorsky M.S., Chen J., Brodsky S. Endothelial cell dysfunction leading to diabetic nephropathy Focus on nitric oxide. Hypertension. 37:2001;744-748
18. Gutterman D.D. Vascular dysfunction in hyperglycemia Is protein kinase C the culprit? Circ Res. 90:2002;5-7
19. Stout R.W. Insulin and atheroma 20-yr perspective. Diabetes Care. 13:1990;631-654
20. Zeng G., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin Direct measurement in vascular endothelial cells. J Clin Invest. 98:1996;894-898
21. Kuboki K., Jiang Z.Y., Takahara N., et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo A specific vascular action of insulin. Circulation. 101:2000;676-681
22. Steinberg H.O., Paradisi G., Hook J.G., et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 49:2000;1231-1238
23. Arcaro G., Cretti A., Balzano S., et al. Insulin causes endothelial dysfunction in humans Sites and mechanisms. Circulation. 105:2002;576-582
24. Gottsater A., Ahmed M., Fernlund P., et al. Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia. Diabet Med. 16:1999;49-54
25. Szelag B., Wroblewski M., Castenfors J., et al. Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care. 22:1999;1907-1908
26. 123I-MIBG. J Nucl Med. 40:1999;6-11
27. Muhr-Becker D., Weiss M., Tatsch K., et al. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus One-year follow-up with improved metabolic control. Exp Clin Endocrinol Diabetes. 107:1999;306-312
28. Watanabe K., Sekiya M., Tsuruoka T., et al. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens. 17:1999;1161-1168
29. Liu J.E., Robbins D.C., Palmieri V., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes The Strong Heart Study. J Am Coll Cardiol. 41:2003;2022-2028
30. Gavras H.P. Issues in hypertension drug tolerability and special populations. Am J Hypertens. 14:(suppl):2001;231S-236S
31. Lender D., Arauz-Pacheco C., Breen L., et al. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens. 12:1999;298-303
32. Kontopoulos A.G., Athyros V.G., Didangelos T.P., et al. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care. 20:1997;355-361
33. Rodgers J.E., Patterson J.H. Angiotensin II-receptor blockers Clinical relevance and therapeutic role. Am J Health Syst Pharm. 58:2001;671-683
34. Lefrandt J.D., Heitmann J., Sevre K., et al. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension The VAMPHYRE study. Am J Hypertens. 14:2001;1083-1089
35. Lasaridis A.N., Sarafidis P.A. Diabetic nephropathy and antihypertensive treatment What are the lessons from clinical trials? Am J Hypertens. 16:2003;689-697
36. Nakamura T., Ushiyama C., Shimada N., et al. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. J Diabetes Complications. 14:2000;250-254
37. Bianchi S., Bigazzi R., Baldari G., et al. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 7:1994;23-29
38. Anan F., Takahashi N., Ooie T., et al. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res. 26:2003;669-676